NCT00449605 - A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes | Biotech Hunter

Enrollment

508

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

March 31, 2009

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Rimonabant

Tablet, oral administration

DRUG

Glimepiride

Tablet, oral administration

DRUG

Metformin

Metformin continued at stable dose as background therapy

Trial Locations (15)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Santiago

Sanofi-aventis adminsitrative office, Santiago

Sanofi-Aventis Administrative Office, Hørsholm

Sanofi-Aventis Administrative Office, Helsinki

Sanofi-Aventis Administrative Office, Budapest

Sanofi-Aventis Administrative Office, Mumbai

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, San Juan

Sanofi-Aventis Administrative Office, Bucharest

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Seoul

Sanofi-Aventis Administrative Office, Barcelona

Sanofi-Aventis Administrative Office, Bromma